AGP Executive Report
Last update: 29 minutes agoAI Safety & Governance: UN chief António Guterres urged tougher, accountable rules for artificial intelligence, warning that “killer robots” must have no place in the future and calling for transparency and independent oversight. Postmarket Drug Follow-Through: A new report highlights how FDA-required long-term safety studies for drugs can be delayed for years, using Tavneos as an example where only a fraction of the planned patient enrollment has occurred despite liver-damage concerns. Military Health & Risk: An F-16 crashed at the U.S. Spangdahlem Air Base in western Germany; the pilot ejected safely and was taken for medical care, with the cause still under investigation. Pharma Investment Pressure in Europe: European drugmakers warned that cash-strapped governments risk falling behind the US and China unless they boost investment conditions for next-generation medicines. Early Type 1 Diabetes Signal: A study in high-risk children links early gut microbiome development patterns to about triple the risk of developing type 1 diabetes, pointing to a potential future monitoring tool.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.